“We are pleased to announce the receipt of a purchase order for over 30 kilograms of high-grade distillate from CannMart,” said Adastra CEO Andy Hale in a statement Friday.
“We expect to receive additional orders as we expand our fulfillment of concentrate products for CannMart's growing line of concentrate offerings with their partner brands.”
Adastra Labs is a British Columbia-based provider of same-site Health Canada licensed cannabis extraction and analytical testing services.
Under the terms of the deal, Adastra will supply standard processing services to CannMart Labs for cannabis extract and concentrate products over a period of 12 months
Following an extensive and rigorous commissioning program, Adastra said it has commenced full-scale processing operations and has taken every precaution possible to safeguard employees, partners and customers during the cornavirus (COVID-19) pandemic.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraha